Skip to content
healthcare.dev

eribulin mesylate

NDC 60505-6435, eribulin mesylate, injection, from Apotex Corp..

Product NDC
60505-6435
Status
Listed
Labeler
Apotex Corp.
Dosage form
INJECTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA218047
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/60505-6435 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ERIBULIN MESYLATE.5 mg/mL

Pharmacologic classes

Microtubule Inhibition [PE]; Microtubule Inhibitor [EPC]

Package NDCNDC-11Package
60505-6435-0605056435001 VIAL, SINGLE-DOSE in 1 CARTON (60505-6435-0) / 2 mL in 1 VIAL, SINGLE-DOSE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/64bf3c30-f06a-3615-ca5e-eb4154d371d0

Use it

Look up 60505-6435 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/60505-6435 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 60505-6435. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.